COMMUNIQUÉS West-GlobeNewswire

Catalyst Pharmaceuticals Introduces New Corporate Website
24/04/2018
CORAL GABLES, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people [...]
Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for May 9
24/04/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., April 24, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Retrotope Announces RT001 Clinical Data Presentation at the 2018 American Academy of Neurology (AAN) Annual Meeting
24/04/2018
Positive Findings from Compassionate Use Study in Patient with Infantile Neuroaxonal Dystrophy (INAD) Presented LOS ALTOS, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today positive findings from a [...]
Golden Leaf Holdings Signs Letter of Intent to Acquire California Cannabis Operation
24/04/2018
Transaction would provide entry into U.S.’s largest growth market for medical and adult-use cannabis TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) ( [...]
Vericel to Report First-Quarter 2018 Financial Results on May 8, 2018
24/04/2018
CAMBRIDGE, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast [...]
Nu-Med Plus Shareholders Re-Elect All 5 Directors at 2018 Shareholder Meeting
24/04/2018
SALT LAKE CITY, April 24, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB: NUMD ), a medical device development company, announced that on April 10, 2018, shareholders voted to re-elect all the existing highly [...]
UroGen Pharma to Ring the Nasdaq Stock Market Opening Bell
24/04/2018
RA’ANANA, Israel and NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Intercept Pharmaceuticals Appoints Nancy Miller-Rich to Its Board of Directors
24/04/2018
NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Radius Health to Announce First Quarter 2018 Financial Results, Host Conference Call and Live Webcast on May 10, 2018
24/04/2018
WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS ) announced today that it will release its first quarter financial results on Thursday, May 10, 2018. The Company will host a conference [...]
PolarityTE Announces Appointment of McKesson’s Willie Bogan to Board of Directors
24/04/2018
SALT LAKE CITY, April 24, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]
Shire plc : Statement re revised proposal
24/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
Avadel Pharmaceuticals to Report First Quarter 2018 Results
24/04/2018
DUBLIN, Ireland, April 24, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ), today announced it will report its first quarter 2018 financial results on Wednesday, May 2, 2018, before the market open. [...]
Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA Conference
24/04/2018
SOUTH SAN FRANCISCO, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) today announced that data from the Phase 2 clinical study of reldesemtiv in patients with spinal muscular [...]
Orion Group Interim Report January-March 2018
24/04/2018
ORION CORPORATION INTERIM REPORT JANUARY-MARCH 2018 24 APRIL 2018 at 12:00 EEST Orion Group Interim Report January-March 2018 Orion's net sales for continuing operations in January-March 2018 totalled EUR 247 million ( [...]
ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.
24/04/2018
LOS ANGELES, April 24, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has entered into a $250,000 initial sales agreement with Vage Nigeria Ltd. (“Vage”), a brand support [...]
Galapagos reports initiation of FALCON clinical trial in cystic fibrosis
24/04/2018
Our first triple combination investigational therapy for CF patients combination of '2451+'2222+'2737 multiple centers in Europe topline results expected Q3 2018 Mechelen, Belgium; 24 April 2018; 08.45 AM CET - [...]
Shire plc : Rule 2.9 Announcement
24/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 April 2018 [...]
Lysogene Signs Partnership Agreement with Dr. Hervé Moine, Researcher at the IGBMC(1) and the SATT(2) Conectus Alsace, in the Fragile X Syndrome
24/04/2018
Development of a gene therapy product for the treatment of patients with Fragile X syndrome Implementation of the project through a unique partnership First results anticipated in 2019 CAMBRIDGE, Mass. and PARIS, April [...]
Interim Report January-March 2018
24/04/2018
Summary Q1 IN BRIEF The study design for PledOx ® Phase III program has been approved by the UK Medicines Agency MHRA and accepted by the US FDA and the Central Ethics Committee of the United States PledOx ® shows [...]

Pages